127 related articles for article (PubMed ID: 2389038)
21. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
22. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
[TBL] [Abstract][Full Text] [Related]
24. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
[TBL] [Abstract][Full Text] [Related]
26. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Jun; 22(5):735-42. PubMed ID: 15172069
[TBL] [Abstract][Full Text] [Related]
27. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
28. Differences in metabolism of fiber tract alterations in gliomas: a combined fiber density mapping and magnetic resonance spectroscopic imaging study.
Stadlbauer A; Hammen T; Buchfelder M; Bachmair J; Dörfler A; Nimsky C; Ganslandt O
Neurosurgery; 2012 Aug; 71(2):454-63. PubMed ID: 22517254
[TBL] [Abstract][Full Text] [Related]
29. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
31. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
32. Imaging of low- and intermediate-grade gliomas.
Ricci PE; Dungan DH
Semin Radiat Oncol; 2001 Apr; 11(2):103-12. PubMed ID: 11285548
[TBL] [Abstract][Full Text] [Related]
33. Experimental and human brain neoplasms: detection with in vivo sodium MR imaging.
Turski PA; Houston LW; Perman WH; Hald JK; Turski D; Strother CM; Sackett JF
Radiology; 1987 Apr; 163(1):245-9. PubMed ID: 3029803
[TBL] [Abstract][Full Text] [Related]
34. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
Anderson JH; Strandberg JD; Wong DF; Conti PS; Barker PB; Blackband SJ; Hilton J; Natarajan TK; Dannals RF; Samphilipo MA
Invest Radiol; 1994 Jun; 29(6):597-605. PubMed ID: 8088967
[TBL] [Abstract][Full Text] [Related]
35. Human brain tumors: assessment with in vivo proton MR spectroscopy.
Ott D; Hennig J; Ernst T
Radiology; 1993 Mar; 186(3):745-52. PubMed ID: 8430183
[TBL] [Abstract][Full Text] [Related]
36. P-31 MR spectroscopy of normal human brain and brain tumors.
Hubesch B; Sappey-Marinier D; Roth K; Meyerhoff DJ; Matson GB; Weiner MW
Radiology; 1990 Feb; 174(2):401-9. PubMed ID: 2296651
[TBL] [Abstract][Full Text] [Related]
37. Chemical shift imaging of human brain: axial, sagittal, and coronal P-31 metabolite images.
Vigneron DB; Nelson SJ; Murphy-Boesch J; Kelley DA; Kessler HB; Brown TR; Taylor JS
Radiology; 1990 Dec; 177(3):643-9. PubMed ID: 2243963
[TBL] [Abstract][Full Text] [Related]
38. Combined 1H-MR imaging and localized 31P-spectroscopy of intracranial tumors in 43 patients.
Heindel W; Bunke J; Glathe S; Steinbrich W; Mollevanger L
J Comput Assist Tomogr; 1988; 12(6):907-16. PubMed ID: 3183124
[TBL] [Abstract][Full Text] [Related]
39. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.
Herholz K; Pietrzyk U; Voges J; Schröder R; Halber M; Treuer H; Sturm V; Heiss WD
J Neurosurg; 1993 Dec; 79(6):853-8. PubMed ID: 8246053
[TBL] [Abstract][Full Text] [Related]
40. Impacts of MR spectroscopic imaging on glioma patient management.
Chronaiou I; Stensjøen AL; Sjøbakk TE; Esmaeili M; Bathen TF
Acta Oncol; 2014 May; 53(5):580-9. PubMed ID: 24628262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
